http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113453665-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a297b7b0dc31d81facdb9cfb00c88f22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2020-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37d0dfe99e2f73b7dbc7d30e120e9405
publicationDate 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113453665-A
titleOfInvention Naloxone formulations for sublingual and/or buccal administration
abstract Liquid, gel, and semi-solid compositions are provided that contain a naloxone base, or an isomer or derivative thereof, and one or more non-aqueous solvents, and optionally a viscosity modifier. Also provided is a method of treating an individual exhibiting symptoms of respiratory depression associated with known or suspected opioid overdose, the method comprising administering a naloxone base, or an isomer or derivative thereof, in one or more Liquid, gel or semi-solid formulations of solutions in a non-aqueous solvent.
priorityDate 2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016007245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018148382-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452341543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449950617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691

Total number of triples: 57.